1. Home
  2. ITRN vs ANNX Comparison

ITRN vs ANNX Comparison

Compare ITRN & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ituran Location and Control Ltd.

ITRN

Ituran Location and Control Ltd.

N/A

Current Price

$52.16

Market Cap

1.0B

Sector

Technology

ML Signal

N/A

Logo Annexon Inc.

ANNX

Annexon Inc.

N/A

Current Price

$4.04

Market Cap

873.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ITRN
ANNX
Founded
1994
2011
Country
Israel
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
873.3M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
ITRN
ANNX
Price
$52.16
$4.04
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
★ $74.50
$15.43
AVG Volume (30 Days)
77.7K
★ 3.1M
Earning Date
11-17-2026
11-09-2026
Dividend Yield
★ 3.86%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.43
N/A
Revenue Next Year
$5.43
N/A
P/E Ratio
$16.85
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.00
$2.54
52 Week High
$68.30
$7.18

Technical Indicators

Market Signals
Indicator
ITRN
ANNX
Relative Strength Index (RSI) 51.80 42.55
Support Level $50.17 $3.71
Resistance Level $53.04 $4.37
Average True Range (ATR) 1.00 0.23
MACD 0.10 0.04
Stochastic Oscillator 73.08 54.67

Price Performance

Historical Comparison
ITRN
ANNX

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: